Quarterly Updates29 May 2026, 06:52 pm
Indo Us Bio-Tech Audited Results for FY26
AI Summary
Indo Us Bio-Tech Ltd. announced its audited financial results for the quarter and year ended March 31, 2026. The Board of Directors approved the standalone audited financial results in a meeting held on May 29, 2026. Revenue from operations stood at ₹11043.91 Lakhs for the year ended March 31, 2026, compared to ₹10363.34 Lakhs in the previous year. Net profit for the year was ₹1312.29 Lakhs. The results include an unmodified audit opinion from Gautam N Associates, Chartered Accountants.
Key Highlights
- Revenue from Operations for FY26 is ₹11043.91 Lakhs.
- Net Profit for FY26 stands at ₹1312.29 Lakhs.
- Auditors issued an unmodified opinion on the financial results.
- Board approved results in meeting held on May 29, 2026.
- Standalone Balance Sheet and Cash Flow statement also approved.
Price Impact
More from INDOUS